A

ADC Therapeutics SA

D
ADCT
USD
-0.255
(-8.0315%)
Market Closed
11,442.00
Volume
-1.59
EPS
-
Div Yield
-1.173228
P/E
282,328,110.28
Market Cap
Today
-8.0315%
1 Week
3.546%
1 Month
-12.312%
6 Months
-39.545%
12 Months
289.333%
Year To Date
74.850%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
C
CIEN
1.82
(2.6569%)
USD
I
INFN
-0.055
(-0.8209%)
USD
J
JNPR
-0.015
(-0.0385%)
USD
CSCO
CSCO
0.24
(0.4149%)
USD
H
HPE
0.105
(0.4921%)
USD
HPQ
HPQ
0.425
(1.1513%)
USD
INTC
INTC
2.905
(12.4438%)
USD
IBM
IBM
0.28
(0.1312%)
USD
DELL
DELL
-0.44
(-0.3181%)
USD
N
NTAP
1.68
(1.3869%)
USD

Title:
ADC Therapeutics SA

Sector:
Healthcare
Industry:
Biotechnology
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.
Do you need help or have a question?
Contact Us